Clinical Trial Update: Phase III China GT 1b Interferon (IFN) Intolerant Prev Exclude Dual [Phase 3]

View source ↗

Summary

Phase III trial update for Hepatitis C in China evaluating interferon intolerance and dual therapy approaches; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Interferon (interferon)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED | Results posted: 2019-07-11